To: Zeev Hed who wrote (9207 ) 3/13/1999 11:11:00 AM From: Rich Wolf Read Replies (3) | Respond to of 27311
Has Castle Creek *really* sold short? I think not. Here's why: The S-3A document from February 1999 lists CC as a "beneficial owner" of 1,375,919 shares of common (from conversion of the Series A preferred stock *at the fixed price*). This document is the filing for the *additional* 1,702,583 shares of common, combining the conversion of the Series B preferred at the assumed fixed price, plus "warrants to purchase up to 895,522 shares of (our) common stock at a price of $6.78 per share" (extracted from the SEC filing). At the time of the filing, the stock had not yet been issued, and CC was still beneficial owner of only 1,375,919 shares. Now here's the important part: If CC were to allow any of their converted or unconverted shares to be sold, sold short, or pledged to another party as collateral, to then be sold short, then CC would be considered a "selling shareholder" by the terms of this document, and the number of shares beneficially owned would be decreased thereby. (See the quote below extracted from the S-3A.) Since the number of shares beneficially owned as of Feb. 10, 1999 has NOT been measurably reduced (if at all) from the amount initially converted from the Series A, then the conclusion is that those shares have NOT been sold short BY ANYONE. As of Feb. 1999, there are currently 1,253,813 shares short. But judging from the wording in this filing, they aren't the shares from the preferred stock sold to Castle Creek. Whoever has sold short WILL still need to cover on the open market. ------------------------------------------------------ Extracted from the S-3A: "From time to time, CC Investments and Gemini Capital may transfer, pledge, donate or assign shares of Valence common stock to lenders or others, and each of such persons will be deemed to be a "selling stockholder" for purposes of the prospectus. The number of the selling stockholders' shares beneficially owned by a selling stockholder who transfers, pledges, donates or assigns shares of our common stock will decrease as and when they take such actions." ------------------------------------------------------------------ I would further point out that the "warrants to purchase up to 895,522 shares of (our) common stock at a price of $6.78 per share" would provide Valence with OVER $6M ADDITIONAL CAPITAL. There are also 175,000 warrants held by Gemini Capital, and the $7.5 loan available from Carl Berg, with its associated warrants. That is why I do NOT view March 31 as a 'drop dead' date for needing cash flow from POs.